Navigation Links
Syndication Inc. CEO asks Board of Directors to Consider Routine Quarterly Stock Dividends
Date:2/26/2009

'As a Public Company, our most Important Asset is our Shareholders,' says Sorrentino

DAMASCUS, Md., Feb. 26 /PRNewswire-FirstCall/ -- Syndication Inc., (Pink Sheets: SYNJ), reports that on February 26th, 2009, the CEO of Syndication asked the BOD to consider declaring quarterly stock dividends, similar to the Dividend currently being issued. "We are a young Public Company with tremendous growth potential, especially with the developments in our green energy program. It is my intension to take every step possible to make our Company successful but more importantly, to allow our long term investing shareholders to share in our maturing wealth. WHY NOT? The way I see it, that is the job of the CEO. It is my position, depending on the results and reception of this first Stock Dividend, to recommend that the Board consider establishing policy that routinely pays a dividend of this type on a quarterly basis," said Sorrentino, the CEO of Syndication.

The Company is currently working through the details with its transfer agent and is expected to approve the resolution to declare its first stock dividend over the next 24 to 48 hours. The Company indicates that more news on the declaration of the stock dividend, developments in the green energy program and the Sy-Med Spinal Decompression Division is pending.

This press release may contain forward-looking statements covered within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to, among other things, plans and timing for the introduction or enhancement of our services and products, statements about future market conditions, supply and demand conditions, and other expectations, intentions and plans contained in this press release that are not historical fact and involve risks and uncertainties. Our expectations regarding future revenues depend upon our ability to develop and supply products, which we may not produce today and that meet defined specifications. When used in this press release, the words "plan," "expect," "believe," and similar expressions generally identify forward-looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties, including, but not limited to, changes in technology and changes in pervasive markets.

New Contact Information: Syndication Inc., Brian Sorrentino, Phone # 888-422-5515

For all mail correspondence; Box 503, Damascus, MD 20872


'/>"/>
SOURCE Syndication Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
2. KGI Elects Three New Members to Board of Trustees
3. Ralf Rosskamp, M.D. Joins Biodels Scientific Advisory Board
4. DOV Pharmaceutical, Inc. Begins Trading on OTC Bulletin Board
5. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
6. BioLife Solutions Expands Scientific Advisory Board
7. NeurogesX Appoints New Director to the Board
8. Genstar Names Michael Hurt to Its Strategic Advisory Board
9. Boston Scientific Announces Election of Ray Elliott to Its Board of Directors
10. Bruce Pasternack Elected to Codexis Board
11. Interleukin Genetics Announces Management and Board Appointments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... ... , ... March 22, 2017...Council for Agricultural Science and Technology, Ames, Iowa. ... innovation in smart, sustainable ways. Humans depend on plants for food, feed, fiber, and ... This paper is the first in a series that connects science and technology to ...
(Date:3/22/2017)... Mass. , March 22, 2017  RXi ... developing innovative therapeutics that address significant unmet medical ... RXi,s Chief Business Officer, will present at the ... forum will provide a platform to present to ... institutes, leading pharmaceutical and biotech companies as well ...
(Date:3/20/2017)... ... March 20, 2017 , ... ... with the ability of endogenous hormones to regulate homeostasis via their cognate ... (antagonists), EDCs produce adverse reproductive, neurological, proliferative, and immunological disorders. EDC exposure ...
(Date:3/20/2017)... ... March 20, 2017 , ... Existing ... preparation methods in order to reduce the impact on instrumentation. ICP-MS is a ... of elemental analysis. , This presentation will discuss the pros and cons ...
Breaking Biology Technology:
(Date:2/21/2017)... and PORTLAND, Ore. , Feb. 22, ... Avamere Family of Companies (Avamere Health Services, Infinity Rehab, ... six-month research study that will apply the power of ... senior living and health centers. By analyzing data streaming ... gain insights into physical and environmental conditions, and obtain ...
(Date:2/14/2017)...  Wake Forest Baptist Medical Center today announced Julie Ann ... officer (CEO). Freischlag joins the medical center on May ... M.D., who last year announced that he would transition ... leading it since 2008.   As CEO, ... Baptist,s academic health system, which includes Wake Forest School ...
(Date:2/10/2017)... 10, 2017 Research and Markets ... "Personalized Medicine - Scientific and Commercial Aspects" to their ... ... is integrated with therapy for selection of treatment as well ... and prevention of disease in modern medicine. Biochip/microarray technologies and ...
Breaking Biology News(10 mins):